Unraveling the molecular mechanism underlying the anticancer activity of CISD2/NAF-144-67
Linda M. Rowland, Itai Alfoni, Ehud Neumann, Ola Karmi, Rachel Nechushtai, Ron Mittler
This study identifies how NAF-144-67 targets CISD2/NAF-1 in cancer cells, disrupts its dimeric structure, and enhances anticancer activity through dimeric forms.
Cancer Letters · Jan 8, 2025Peer-reviewedCancer Biology